Autopsy report · NCT03467620

Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease

“Inadequate funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2, Phase 3

Sponsor

University of Illinois at Chicago

Sponsor type

University, hospital or other

Conditions

Crohn Disease; Inflammatory Bowel Diseases; Cannabis

Interventions

Cannabidiol; Placebo oral capsule

Participants

0

Trials that died the same way

• PROtecting Maternal Brains From Injury and Stroke
  “Lack of funding” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.